Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment. A new study¹ by Vahakn Shahinian and Yong-Fang Kuo from the Universities of Michigan and Texas respectively, finds that although bone mineral density testing is carried out on some men receiving this therapy, it is not routine. They did note, however, that men were significantly more likely to be tested when they were being cared for by both a urologist and a primary care physician. Read more here.
Study mentioned: Shahinian VB, Kuo YF. Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer. J Gen Intern Med. 2013 May 14. [Epub ahead of print] PMID: 23670565
No comments:
Post a Comment